Salix Pharmaceuticals Ltd (NASDAQ:SLXP)

172.60
Delayed Data
As of Mar 27
 -0.03 / -0.02%
Today’s Change
86.00
Today|||52-Week Range
172.98
+50.17%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues403.0M382.0M341.5M13.5M
 
 
 
 
 
Cost of Goods Sold114.8M102.1M83.7M26.9M
 
 
 
 
 
Depreciation And Amortization56.1M57.1M56.5M57.6M
 
 
 
 
 
 
Operating ExpensesGross Income232.1M222.8M201.4M-71.0M
 
 
 
 
 
General Expenses161.9M185.1M214.3M193.7M
 
 
 
 
 
Research And Development41.2M39.2M36.7M66.8M
 
 
 
 
 
Total Operating Expenses332.8M344.3M354.4M278.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income70.2M37.7M-12.9M-264.7M
 
 
 
 
 
Extraordinary Credit0.000.00--13.8M
 
 
Extraordinary Charge-90.4M-50.5M-76.5M-172.6M
 
 
 
 
 
Interest Expense On Debt42.7M0.0043.0M42.6M
 
 
 
 
Other Expenses-91.0K-323.0K-1.7M-1.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-62.6M6.0M-134.2M-467.3M
 
 
 
 
 
Income Taxes-28.0M-2.7M-41.0M-179.7M
 
 
 
 
 
Net Income-34.6M3.3M-93.1M-287.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS63.3M63.4M63.7M63.8M
 
 
 
 
 
Shares To Calculate EPS Diluted63.3M75.5M63.7M63.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.55$0.04-$1.46-$4.51
 
 
 
 
 
EPS Diluted-$0.55$0.04-$1.46-$4.51
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account